Sareddy et al. [21] investigated the status and significance of ERβ signaling in gliomas through the use of both in vitro and in vivo xenograft models of gliomas and tested its therapeutic significance using recently developed selective ERβ modulators. The gene discussed is ESR2; the disease is central nervous system cancer.